<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698995</url>
  </required_header>
  <id_info>
    <org_study_id>ID AN-002-14</org_study_id>
    <nct_id>NCT02698995</nct_id>
  </id_info>
  <brief_title>Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia</brief_title>
  <official_title>Analgetic Efficiency of Single-shot Perineural Low Dose Dexamethasone Added to Infraclavicular Block Anesthesia for Upper Limb Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foisor Orthopedics Clinical Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Foisor Orthopedics Clinical Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexamethasone has an evidence-based indication in postoperative emesis prophylaxy and as a
      antiinflammatory steroid. Although the perineural administration is off-label, several
      studies recognised its analgetic action as an adjuvant for peripheral nerves blockade,
      permitting to reduce the concentration of the local anesthetics and extending the sensory and
      motor block.Questions remain concerning the mechanism of action, optimal dose, the
      lack/degree of toxicity and the comparison with intravenous administration.The aim of this
      prospective randomized controlled study is to investigate the efficacy of analgesia with 4 mg
      or 2 mg Dexamethasone added to a combination of ropivacaine 0,5% and lidocaine 1% in vertical
      infraclavicular blockade (VIB) anesthesia for upper limb surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators conducted a prospective randomized controlled study in 150 patients
      American Society of Anesthesiologists (ASA) score I-III scheduled for upper limb surgery ,
      divided in 3 groups: group A received anesthesia VIB block with ropivacaine 0,5% 100 mg
      +lidocaine 1%+1 ml saline; group B received VIB block with ropivacaine 0,5% 100 mg +lidocaine
      1% + 2 mg dexamethasone; group C received ropivacaine 0,5% 100 mg +lidocaine 1% + 4 mg
      dexamethasone.The anesthesiologist may use the ultrasound for visual guidance, but should
      also use the nerve stimulator in order to maintain the homogeneity of the procedure.

      Intraoperative sedation was provided with intermittent bolus 10-20 mg IV Propofol.
      Postoperatively all patients received the same analgetic protocol when Visual Analog Pain
      Scale (VAS) over 3 with IV Perfalgan and Lornoxicam 8 mg/12 hours for 24 hours. If after 30
      minutes VAS is still over 3, a loading dose of morphine 0,05 mg/kg should be administered. At
      first analgetic request, the nurse conducts an ice-probe test to both arms and will note the
      answer: same cold, slightly burn, burn, aching with the reason to test the potentially
      hyperalgesia effect related to ropivacaine. The data recorded are: time to first analgetic
      use, VAS at block regression, ice-probe test, motor and sensitive block duration, glycemic
      variations at 4 h, neurological complications immediately after block, total morphine
      consumption.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensory block duration</measure>
    <time_frame>First 24 hours</time_frame>
    <description>The time in minutes measured between VIB block to first analgetic request</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor block duration</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>The time in minutes measured between VIB block to complete movement of the hand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic variations at 4 hours post-VIB block</measure>
    <time_frame>First 4 hours postoperatively</time_frame>
    <description>Determination of blood sugar level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients opioid free analgesia</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Number of reported patients with no need opioid analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS at the block regression</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>VAS evaluation on the VAS scale (0 - no pain, 10 - the worst pain possible )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cutaneous temperature ice-probe</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>The cold sensation on ice-probe test to both arms could be the same or burn likely</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption at 24 hours</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Cumulative morphine administration in milligrams</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>VIB block with ropivacaine 0,5%100 mg+lidocaine1%100 mg+1 ml saline=21 ml. After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.05 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VIB block with ropivacaine 0,5%100 mg+lidocaine1%100 mg+2 mg dexamethasone=21 ml. After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.05 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VIB block with ropivacaine 0,5%100 mg+lidocaine1%100 mg+4 mg dexamethasone=21 ml. After the block regression, at the first analgetic request the patients received the analgesia protocol was started for 24 h with paracetamol 1 g IV every 8 h and lornoxicam 8 mg PO every 12 h; if VAS was still over 3 after 30 min, morphine was given as a loading bolus of 0.05 mg/kg IV supplemented with 2 mg IV every 5 minutes until VAS &lt;3. After 2 h morphine was administered SC ½ of the total loading dose at request.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>One hour before surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>One hour before surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>After the block regression, at the first analgetic request the patients received the same analgesia protocol</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Perfalgan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>After the block regression, at the first analgetic request the patients received the same analgesia protocol</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Morphine Sulfate ER</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>One hour before surgery the patients received single shot VIB block with the mixture according to the group allocation</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III,

          -  BMI&lt;40,

          -  non-anemic

        Exclusion Criteria:

          -  High risk grade hypertension, chronic renal failure, known allergy to local anesthetic
             or NSAIDs, chronic treatment with steroids, drugs dependency, history of diabetes
             mellitus, ulcer or chronic gastritis, infection on the puncture site, chronic
             obstructive pulmonary disease, neuropathy at the surgical level
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioan Cristian Stoica, MD Prof</last_name>
    <role>Study Director</role>
    <affiliation>Foisor Orthopedics Clinical Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana Maria Munteanu, MD PhD</last_name>
    <phone>0040722514156</phone>
    <email>ammunteanu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denisa Anastase, MD PhD</last_name>
    <phone>0040721255339</phone>
    <email>danastase1@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foisor Orthopedic Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>021383</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Maria Munteanu, MD PhD</last_name>
      <phone>0040722514156</phone>
      <email>ammunteanu@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Denisa Anastase, MD PhD</last_name>
      <phone>0040721255339</phone>
      <email>danastase1@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Simona Florescu Cionac, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ioan Cristian Stoica, MD Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <results_reference>
    <citation>Kalichman MW, Powell HC, Myers RR. Pathology of local anesthetic-induced nerve injury. Acta Neuropathol. 1988;75(6):583-9.</citation>
    <PMID>3376761</PMID>
  </results_reference>
  <results_reference>
    <citation>Myers RR, Kalichman MW, Reisner LS, Powell HC. Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology. 1986 Jan;64(1):29-35.</citation>
    <PMID>3942334</PMID>
  </results_reference>
  <results_reference>
    <citation>Zink W, Graf BM. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine. Curr Opin Anaesthesiol. 2008 Oct;21(5):645-50. doi: 10.1097/ACO.0b013e32830c214c. Review.</citation>
    <PMID>18784493</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011 May-Jun;36(3):225-30. doi: 10.1097/AAP.0b013e3182176f70.</citation>
    <PMID>21519308</PMID>
  </results_reference>
  <results_reference>
    <citation>Huynh TM, Marret E, Bonnet F. Combination of dexamethasone and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2015 Nov;32(11):751-8. doi: 10.1097/EJA.0000000000000248. Review.</citation>
    <PMID>25774458</PMID>
  </results_reference>
  <results_reference>
    <citation>Kawanishi R, Yamamoto K, Tobetto Y, Nomura K, Kato M, Go R, Tsutsumi YM, Tanaka K, Takeda Y. Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local Reg Anesth. 2014 Apr 5;7:5-9. doi: 10.2147/LRA.S59158. eCollection 2014.</citation>
    <PMID>24817819</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2016</study_first_submitted>
  <study_first_submitted_qc>February 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>August 9, 2016</last_update_submitted>
  <last_update_submitted_qc>August 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Foisor Orthopedics Clinical Hospital</investigator_affiliation>
    <investigator_full_name>Munteanu Ana Maria, MD, PhD</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

